The Iopamidol Injection, cataloged under National Stock Number 6505-01-276-6153, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Bracco Diagnostics Inc.. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-276-6153 |
| Primary Part Number | NDC00270-1316-45 |
| Item Name | Iopamidol Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Bracco Diagnostics Inc. |
| Status | ACTIVE |
| Administration | INTRAVASCULAR |
| Primary Container Content Quantity | 200.000 MILLILITERS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 76.000 PERCENTAGE, W/V IOPAMIDOL ACTIVE INGREDIENT |
| Total Primary Container Quantity | 10 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC00270-1316-45 PRIMARY | Bracco Diagnostics Inc. (USA) |
| Reference | Meaning |
|---|---|
| NDC00270-1316-40 | 3/9 Design control — primary reference Bracco Diagnostics Inc. |
| NDC00003-1316-40 | 5/9 Secondary reference Squibb E R and Sons Inc World Hq |
NSN 6505-01-276-6153 is a Iopamidol Injection, manufactured by Bracco Diagnostics Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-276-6153 has 1 manufacturer part number on file: NDC00270-1316-45 (Bracco Diagnostics Inc.).
Key specifications for NDC00270-1316-45: Administration: INTRAVASCULAR; Primary Container Content Quantity: 200.000 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE. 6 specifications are documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.